Warfarin sodium (CAS 129-06-6) — formula C19H15O4.Na, molecular weight 330.3; category pharmaceutical intermediates and APIs.
Warfarin sodium (CAS 129-06-6) is a chemical raw material in the pharmaceutical intermediates and APIs category. Its molecular formula C19H15O4.Na comprises 19 C, 15 H, 4 O, 1 Na atoms. Its molecular weight is about 330.3. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.
| CAS Number | 129-06-6 |
|---|---|
| Molecular Formula | C19H15O4.Na |
| Molecular Weight | 330.3 |
| Applications | Warfarin is an anticoagulant drug and rodenticide derived from coumarin. As a drug it is used for the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia |
| Category | Pharmaceutical Intermediates & APIs |
Documented applications: Warfarin is an anticoagulant drug and rodenticide derived from coumarin. As a drug it is used for the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia.
Warfarin sodium is a pharmaceutical intermediate or API compound with CAS registry number 129-06-6 and molecular formula C19H15O4.Na (molecular weight 330.3), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.
CAS number: 129-06-6
Its molecular formula C19H15O4.Na comprises 19 C, 15 H, 4 O, 1 Na atoms.
Also known as: Warfarin sodium · 3-(A-丙酮基苄基)-4-羟基香豆素 · 3-(A-acetonylbenzyl)-4-hydroxycoumarin
Category: pharmaceutical intermediates and APIs
The CAS registry number of Warfarin sodium is 129-06-6.
Molecular formula C19H15O4.Na, molecular weight 330.3.
It is also registered under: Warfarin sodium, 3-(A-丙酮基苄基)-4-羟基香豆素, 3-(A-acetonylbenzyl)-4-hydroxycoumarin.
Recorded applications: Warfarin is an anticoagulant drug and rodenticide derived from coumarin. As a drug it is used for the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia.
Category: Pharmaceutical Intermediates & APIs.
Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.
Independent reference data for Warfarin sodium (CAS 129-06-6), compiled from public chemistry databases.
| CAS Registry Number | 129-06-6 |
|---|---|
| PubChem CID | 16204922 |
| Molecular formula | C19H15O4.Na |
| IUPAC name | sodium 2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate |
| UNII (FDA) | 6153CWM0CL |
| Molecular Weight | 330.3 |
|---|---|
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 330.08680324 |
| Monoisotopic Mass | 330.08680324 |
| Topological Polar Surface Area | 66.4 |
| Heavy Atom Count | 24 |
| Vapor Pressure | 0.00001 [mm Hg] @25 °C |
|---|
Warfarin sodium; Sodium warfarin; Aldocumar; Jantoven; Marevan; Athrombin; Prothromadin; Zoocoumarin sodium salt; Tintorane; Warcoumin; Warfilone; Varfine; Warfarin sodium salt; Coumadin sodium; Ratsul soluble; Sodium coumadin
| Reported hazard statements | H300 (99.1%), H310 (49.1%), H330 (49.1%), H360 (100%), H372 (49.1%) |
|---|
H300 (99.1%): Fatal if swallowed [Danger Acute toxicity, oral]
H310 (49.1%): Fatal in contact with skin [Danger Acute toxicity, dermal]
3-(A-acetonylbenzyl)-4-hydroxycoumarin · CAS 129-06-6 · C19H15O4.Na. UNII 6153CWM0CL. Vapor Pressure: 0.00001 [mm Hg] @25 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 3-(A-丙酮基苄基)-4-羟基香豆素